Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus

A series of trans-tetrahydro-4-hydroxy-6-[2-(2,3,4,5-substituted-1H-pyrrol-1-yl) ethyl]-2H-pyran-2-ones and their dihydroxy acids were prepared and tested for their ability to inhibit the enzyme HMG-CoA reductase in vitro. Inhibitory potency was found to increase substantially when substituents were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1991-01, Vol.34 (1), p.357-366
Hauptverfasser: Roth, Bruce D, Blankley, C. J, Chucholowski, A. W, Ferguson, E, Hoefle, M. L, Ortwine, D. F, Newton, R. S, Sekerke, C. S, Sliskovic, D. R, Wilson, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 366
container_issue 1
container_start_page 357
container_title Journal of medicinal chemistry
container_volume 34
creator Roth, Bruce D
Blankley, C. J
Chucholowski, A. W
Ferguson, E
Hoefle, M. L
Ortwine, D. F
Newton, R. S
Sekerke, C. S
Sliskovic, D. R
Wilson, M
description A series of trans-tetrahydro-4-hydroxy-6-[2-(2,3,4,5-substituted-1H-pyrrol-1-yl) ethyl]-2H-pyran-2-ones and their dihydroxy acids were prepared and tested for their ability to inhibit the enzyme HMG-CoA reductase in vitro. Inhibitory potency was found to increase substantially when substituents were introduced into positions three and four of the pyrrole ring. A systematic exploration of structure-activity relationships at these two positions led to the identification of a compound ((+)-33,(+)-(4R)-trans-2-(4-fluororphenyl)-5-(1-methylethyl)-N,3- diphenyl-1- [(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-4- carboxamide) with five times the inhibitory potency of the fungal metabolite compactin.
doi_str_mv 10.1021/jm00105a056
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80435679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80435679</sourcerecordid><originalsourceid>FETCH-LOGICAL-a335t-5d0f6806fe93a6186d9fdf8c7afe310bb4d48dd4a2d49bb41dd05f472a93f9e13</originalsourceid><addsrcrecordid>eNptkUuLFDEUhQtRxnZ05VrIygeSNo96Lsdm7B5oUZh2JRJSlRsrbXXSk6Rg6gf7P8x0DT7A1SU5331wTpY9p2RJCaPv9gdCKCkkKcoH2YIWjOC8JvnDbEEIY5iVjD_OnoSwJ4RwyvhZdkabhlFeLbKfV7Y3rYnOB-Q06no3QIjg3YBa48JkYw_BhCXiS7SD6GU_Ke9wjk_1dsIl_srwa7rBx8mnLkzxNLyB2E_DN8xOv9Iihp0FZP5Ztfm4xit3gTyosYsywBKxJbrUGrp4AoyN3iXN2O8ojG2IJo5gkyYjOrpgonE2oNh7ACStQtqN_q4vXYzmYwDZsRtgDE-zR1oOAZ7d1_Psy4fL3WqDt5_WV6uLLZacFxEXiuiyJqWGhsuS1qVqtNJ1V0kNnJK2zVVeK5VLpvImvahSpNB5xWTDdQOUn2cv57lH727GZKQ4mNDBMEgLbgwipcKLsmoS-HYGO-9C8KDF0ZuD9JOgRNyFKv4KNdEv7seO7QHUH3ZOMel41k2K7va3LP0PUVa8KsTu87Wgq-31-_WqFrvEv5p52QWxT7bZZMp_N_8CcwC71A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80435679</pqid></control><display><type>article</type><title>Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus</title><source>ACS Publications</source><source>MEDLINE</source><creator>Roth, Bruce D ; Blankley, C. J ; Chucholowski, A. W ; Ferguson, E ; Hoefle, M. L ; Ortwine, D. F ; Newton, R. S ; Sekerke, C. S ; Sliskovic, D. R ; Wilson, M</creator><creatorcontrib>Roth, Bruce D ; Blankley, C. J ; Chucholowski, A. W ; Ferguson, E ; Hoefle, M. L ; Ortwine, D. F ; Newton, R. S ; Sekerke, C. S ; Sliskovic, D. R ; Wilson, M</creatorcontrib><description>A series of trans-tetrahydro-4-hydroxy-6-[2-(2,3,4,5-substituted-1H-pyrrol-1-yl) ethyl]-2H-pyran-2-ones and their dihydroxy acids were prepared and tested for their ability to inhibit the enzyme HMG-CoA reductase in vitro. Inhibitory potency was found to increase substantially when substituents were introduced into positions three and four of the pyrrole ring. A systematic exploration of structure-activity relationships at these two positions led to the identification of a compound ((+)-33,(+)-(4R)-trans-2-(4-fluororphenyl)-5-(1-methylethyl)-N,3- diphenyl-1- [(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-4- carboxamide) with five times the inhibitory potency of the fungal metabolite compactin.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00105a056</identifier><identifier>PMID: 1992137</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Anticholesteremic Agents - chemical synthesis ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Indicators and Reagents ; Liver - enzymology ; Magnetic Resonance Spectroscopy ; Molecular Structure ; Pyrones - chemical synthesis ; Pyrones - chemistry ; Pyrones - pharmacology ; Pyrroles - chemical synthesis ; Pyrroles - chemistry ; Pyrroles - pharmacology ; Rats ; Spectrophotometry, Infrared ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1991-01, Vol.34 (1), p.357-366</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a335t-5d0f6806fe93a6186d9fdf8c7afe310bb4d48dd4a2d49bb41dd05f472a93f9e13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00105a056$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00105a056$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1992137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roth, Bruce D</creatorcontrib><creatorcontrib>Blankley, C. J</creatorcontrib><creatorcontrib>Chucholowski, A. W</creatorcontrib><creatorcontrib>Ferguson, E</creatorcontrib><creatorcontrib>Hoefle, M. L</creatorcontrib><creatorcontrib>Ortwine, D. F</creatorcontrib><creatorcontrib>Newton, R. S</creatorcontrib><creatorcontrib>Sekerke, C. S</creatorcontrib><creatorcontrib>Sliskovic, D. R</creatorcontrib><creatorcontrib>Wilson, M</creatorcontrib><title>Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A series of trans-tetrahydro-4-hydroxy-6-[2-(2,3,4,5-substituted-1H-pyrrol-1-yl) ethyl]-2H-pyran-2-ones and their dihydroxy acids were prepared and tested for their ability to inhibit the enzyme HMG-CoA reductase in vitro. Inhibitory potency was found to increase substantially when substituents were introduced into positions three and four of the pyrrole ring. A systematic exploration of structure-activity relationships at these two positions led to the identification of a compound ((+)-33,(+)-(4R)-trans-2-(4-fluororphenyl)-5-(1-methylethyl)-N,3- diphenyl-1- [(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-4- carboxamide) with five times the inhibitory potency of the fungal metabolite compactin.</description><subject>Animals</subject><subject>Anticholesteremic Agents - chemical synthesis</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors</subject><subject>Indicators and Reagents</subject><subject>Liver - enzymology</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Molecular Structure</subject><subject>Pyrones - chemical synthesis</subject><subject>Pyrones - chemistry</subject><subject>Pyrones - pharmacology</subject><subject>Pyrroles - chemical synthesis</subject><subject>Pyrroles - chemistry</subject><subject>Pyrroles - pharmacology</subject><subject>Rats</subject><subject>Spectrophotometry, Infrared</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkUuLFDEUhQtRxnZ05VrIygeSNo96Lsdm7B5oUZh2JRJSlRsrbXXSk6Rg6gf7P8x0DT7A1SU5331wTpY9p2RJCaPv9gdCKCkkKcoH2YIWjOC8JvnDbEEIY5iVjD_OnoSwJ4RwyvhZdkabhlFeLbKfV7Y3rYnOB-Q06no3QIjg3YBa48JkYw_BhCXiS7SD6GU_Ke9wjk_1dsIl_srwa7rBx8mnLkzxNLyB2E_DN8xOv9Iihp0FZP5Ztfm4xit3gTyosYsywBKxJbrUGrp4AoyN3iXN2O8ojG2IJo5gkyYjOrpgonE2oNh7ACStQtqN_q4vXYzmYwDZsRtgDE-zR1oOAZ7d1_Psy4fL3WqDt5_WV6uLLZacFxEXiuiyJqWGhsuS1qVqtNJ1V0kNnJK2zVVeK5VLpvImvahSpNB5xWTDdQOUn2cv57lH727GZKQ4mNDBMEgLbgwipcKLsmoS-HYGO-9C8KDF0ZuD9JOgRNyFKv4KNdEv7seO7QHUH3ZOMel41k2K7va3LP0PUVa8KsTu87Wgq-31-_WqFrvEv5p52QWxT7bZZMp_N_8CcwC71A</recordid><startdate>19910101</startdate><enddate>19910101</enddate><creator>Roth, Bruce D</creator><creator>Blankley, C. J</creator><creator>Chucholowski, A. W</creator><creator>Ferguson, E</creator><creator>Hoefle, M. L</creator><creator>Ortwine, D. F</creator><creator>Newton, R. S</creator><creator>Sekerke, C. S</creator><creator>Sliskovic, D. R</creator><creator>Wilson, M</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910101</creationdate><title>Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus</title><author>Roth, Bruce D ; Blankley, C. J ; Chucholowski, A. W ; Ferguson, E ; Hoefle, M. L ; Ortwine, D. F ; Newton, R. S ; Sekerke, C. S ; Sliskovic, D. R ; Wilson, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a335t-5d0f6806fe93a6186d9fdf8c7afe310bb4d48dd4a2d49bb41dd05f472a93f9e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Animals</topic><topic>Anticholesteremic Agents - chemical synthesis</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors</topic><topic>Indicators and Reagents</topic><topic>Liver - enzymology</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Molecular Structure</topic><topic>Pyrones - chemical synthesis</topic><topic>Pyrones - chemistry</topic><topic>Pyrones - pharmacology</topic><topic>Pyrroles - chemical synthesis</topic><topic>Pyrroles - chemistry</topic><topic>Pyrroles - pharmacology</topic><topic>Rats</topic><topic>Spectrophotometry, Infrared</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roth, Bruce D</creatorcontrib><creatorcontrib>Blankley, C. J</creatorcontrib><creatorcontrib>Chucholowski, A. W</creatorcontrib><creatorcontrib>Ferguson, E</creatorcontrib><creatorcontrib>Hoefle, M. L</creatorcontrib><creatorcontrib>Ortwine, D. F</creatorcontrib><creatorcontrib>Newton, R. S</creatorcontrib><creatorcontrib>Sekerke, C. S</creatorcontrib><creatorcontrib>Sliskovic, D. R</creatorcontrib><creatorcontrib>Wilson, M</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roth, Bruce D</au><au>Blankley, C. J</au><au>Chucholowski, A. W</au><au>Ferguson, E</au><au>Hoefle, M. L</au><au>Ortwine, D. F</au><au>Newton, R. S</au><au>Sekerke, C. S</au><au>Sliskovic, D. R</au><au>Wilson, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1991-01-01</date><risdate>1991</risdate><volume>34</volume><issue>1</issue><spage>357</spage><epage>366</epage><pages>357-366</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>A series of trans-tetrahydro-4-hydroxy-6-[2-(2,3,4,5-substituted-1H-pyrrol-1-yl) ethyl]-2H-pyran-2-ones and their dihydroxy acids were prepared and tested for their ability to inhibit the enzyme HMG-CoA reductase in vitro. Inhibitory potency was found to increase substantially when substituents were introduced into positions three and four of the pyrrole ring. A systematic exploration of structure-activity relationships at these two positions led to the identification of a compound ((+)-33,(+)-(4R)-trans-2-(4-fluororphenyl)-5-(1-methylethyl)-N,3- diphenyl-1- [(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-4- carboxamide) with five times the inhibitory potency of the fungal metabolite compactin.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>1992137</pmid><doi>10.1021/jm00105a056</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1991-01, Vol.34 (1), p.357-366
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_80435679
source ACS Publications; MEDLINE
subjects Animals
Anticholesteremic Agents - chemical synthesis
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Indicators and Reagents
Liver - enzymology
Magnetic Resonance Spectroscopy
Molecular Structure
Pyrones - chemical synthesis
Pyrones - chemistry
Pyrones - pharmacology
Pyrroles - chemical synthesis
Pyrroles - chemistry
Pyrroles - pharmacology
Rats
Spectrophotometry, Infrared
Structure-Activity Relationship
title Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A49%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitors%20of%20cholesterol%20biosynthesis.%203.%20Tetrahydro-4-hydroxy-6-%5B2-(1H-pyrrol-1-yl)ethyl%5D-2H-pyran%202-one%20inhibitors%20of%20HMG-CoA%20reductase.%202.%20Effects%20of%20introducing%20substituents%20at%20positions%20three%20and%20four%20of%20the%20pyrrole%20nucleus&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Roth,%20Bruce%20D&rft.date=1991-01-01&rft.volume=34&rft.issue=1&rft.spage=357&rft.epage=366&rft.pages=357-366&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm00105a056&rft_dat=%3Cproquest_cross%3E80435679%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80435679&rft_id=info:pmid/1992137&rfr_iscdi=true